Suppr超能文献

预测慢性心力衰竭180天再入院风险列线图的开发与验证:一项多中心前瞻性研究

Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A Multicenter Prospective Study.

作者信息

Gao Shanshan, Yin Gang, Xia Qing, Wu Guihai, Zhu Jinxiu, Lu Nan, Yan Jingyi, Tan Xuerui

机构信息

Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College (SUMC), Cardiology, Shantou, China.

Heart Failure center, Qingdao Central Hospital, Cardiology, Qingdao, China.

出版信息

Front Cardiovasc Med. 2021 Sep 7;8:731730. doi: 10.3389/fcvm.2021.731730. eCollection 2021.

Abstract

The existing prediction models lack the generalized applicability for chronic heart failure (CHF) readmission. We aimed to develop and validate a widely applicable nomogram for the prediction of 180-day readmission to the patients. We prospectively enrolled 2,980 consecutive patients with CHF from two hospitals. A nomogram was created to predict 180-day readmission based on the selected variables. The patients were divided into three datasets for development, internal validation, and external validation (mean age: 74.2 ± 14.1, 73.8 ± 14.2, and 71.0 ± 11.7 years, respectively; sex: 50.2, 48.8, and 55.2% male, respectively). At baseline, 102 variables were submitted to the least absolute shrinkage and selection operator (Lasso) regression algorithm for variable selection. The selected variables were processed by the multivariable Cox proportional hazards regression modeling combined with univariate analysis and stepwise regression. The model was evaluated by the concordance index (C-index) and calibration plot. Finally, the nomogram was provided to visualize the results. The improvement in the regression model was calculated by the net reclassification index (NRI) (with tenfold cross-validation and 200 bootstraps). Among the selected 2,980 patients, 1,696 (56.9%) were readmitted within 180 days, and 1,502 (50.4%) were men. A nomogram was established by the results of Lasso regression, univariate analysis, stepwise regression and multivariate Cox regression, as well as variables with clinical significance. The values of the C-index were 0.75 [95% confidence interval (CI): 0.72-0.79], 0.75 [95% CI: 0.69-0.81], and 0.73 [95% CI: 0.64-0.83] for the development, internal validation, and external validation datasets, respectively. Calibration plots were provided for both the internal and external validation sets. Five variables including history of acute heart failure, emergency department visit, age, blood urea nitrogen level, and beta blocker usage were considered in the final prediction model. When adding variables involving hospital discharge way, alcohol taken and left bundle branch block, the calculated values of NRI demonstrated no significant improvements. A nomogram for the prediction of 180-day readmission of patients with CHF was developed and validated based on five variables. The proposed methodology can improve the accurate prediction of patient readmission and have the wide applications for CHF.

摘要

现有的预测模型缺乏对慢性心力衰竭(CHF)再入院的广泛适用性。我们旨在开发并验证一种广泛适用的列线图,用于预测患者180天再入院情况。我们前瞻性地连续纳入了两家医院的2980例CHF患者。基于所选变量创建了一个列线图来预测180天再入院情况。患者被分为三个数据集用于模型开发、内部验证和外部验证(平均年龄分别为:74.2±14.1岁、73.8±14.2岁和71.0±11.7岁;性别:男性分别占50.2%、48.8%和55.2%)。在基线时,将102个变量提交给最小绝对收缩和选择算子(Lasso)回归算法进行变量选择。所选变量通过多变量Cox比例风险回归建模结合单变量分析和逐步回归进行处理。通过一致性指数(C指数)和校准图对模型进行评估。最后,提供列线图以直观呈现结果。通过净重新分类指数(NRI)计算回归模型的改进情况(采用十折交叉验证和200次自抽样)。在所选的2980例患者中,1696例(56.9%)在180天内再入院,1502例(50.4%)为男性。根据Lasso回归结果、单变量分析、逐步回归和多变量Cox回归以及具有临床意义的变量建立了列线图。开发数据集、内部验证数据集和外部验证数据集的C指数值分别为0.75[95%置信区间(CI):0.72 - 0.79]、0.75[95%CI:0.69 - 0.81]和0.73[95%CI:0.64 - 0.83]。为内部和外部验证集均提供了校准图。最终预测模型考虑了包括急性心力衰竭病史、急诊科就诊、年龄、血尿素氮水平和β受体阻滞剂使用情况在内的五个变量。当加入涉及出院方式、饮酒情况和左束支传导阻滞的变量时,NRI计算值无显著改善。基于五个变量开发并验证了一种用于预测CHF患者180天再入院情况的列线图。所提出的方法可以提高对患者再入院的准确预测,并在CHF中有广泛应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1808/8452908/be1c27faaacd/fcvm-08-731730-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验